Press Releases

22 Nov 2012

FPAHK advocates advanced provision of emergency contraceptive pill

The Family Planning Association of Hong Kong (FPAHK) advocates advanced provision of emergency contraceptive pills (ECP) to facilitate its timely use.

Emergency contraception (EC) is offered by FPAHK as a safe and effective back-up measure after contraceptive accidents, errors or omissions to prevent unplanned pregnancy. Two methods are currently available, namely the levonorgestrel pill and the copper intra-uterine contraceptive device (IUCD). One tablet of levonorgestrel pill has to be taken within 72 hours of unprotected intercourse, the earlier the more effective. Its overall failure rate is 2-3%. The copper IUCD has to be inserted by doctor within 120 hours of unprotected intercourse. Its failure rate is 0.09%, and it can be retained for continued contraception after the episode of emergency contraception.

Dr Sue Lo, Senior Doctor, FPAHK said the benefits of advanced provision of ECP include increased accessibility and timely use, which can theoretically decrease the chance of unplanned conception. On the other hand, advanced provision of ECP is not without concern, as it may encourage women to abandon regular contraceptives, increase their risk of sexually transmitted infections (STI) due to reduced condom use, and even lead to an irresponsible attitude towards sex, she said.

In view of these concerns, FPAHK had conducted a number of studies to explore the feasibility of providing ECP in advance. These studies examined the profile of EC users, pattern of EC use, women’s ability to handle ECP provided in advance, their pattern of contraceptive use after EC and their attitude towards advanced provision. These studies have been published in international and local peer-reviewed journals.

Between 2001 and 2002, a randomized controlled study on the effect of advanced provision of ECP was conducted on 1,030 women from the Birth Control Clinic (BCC) and Youth Health Care Centre (YHCC) (Human Reproduction 2004;19:2404-10). Women randomized to the advanced provision group were given 3 courses of ECP to keep at home while those randomized to the clinic group had to return to the clinic for EC when they needed it. Contraceptive counselling including education on EC was provided to both groups. In the whole group, 78% of women did not use a single course of ECP within one year and 9% women used more than one course. Among women who had used at least one course of ECP, those in the advanced provision group used three times more ECP than those in the clinic group in both BCC and YHCC. Women with pills on hand could take it earlier than those who need to go back to the clinic. The average time between coitus and treatment was 13.9 hours versus 28.5 hours. During the one year follow-up, no change in contraceptive practice was observed in both groups. 90% of women used condom and 60% of women used condom regularly before and after the study.

The results indicated that advanced provision of ECP increased its timely use without encouraging repeat use or abandonment of regular contraceptives, and women were capable of using it correctly on their own, Dr Lo explained.

She stressed that EC is an important back-up for contraceptive failure and the EC visit also provides an opportunity for health professionals to discuss with women their contraceptive plan and to motivate them to use contraceptives. In a retrospective analysis of 9,201 women seeking EC from FPAHK between 2006 and 2008, about 20% of them did not use any contraceptive methods at the time of EC. At the follow-up visit 4 to 6 weeks later, the proportion of non-contraceptive users dropped to less than 5% and remained low in the first year. The proportion of those who had adopted a highly effective method, such as hormonal contraceptives or IUCD, increased from 3.5% before having EC to 20.8% at the follow-up visit, and to 27.3% and 27.7% respectively at 6 and 12 months. The proportion of those using less effective methods such as condoms, safety period, withdrawal and spermicides also dropped over time (International Journal of Gynecology & Obstetrics 2012; 118: 223-6).

Among women who sought EC from FPAHK during this three year period, the major reasons for seeking EC were contraceptive omission (39%), condom accident (38%) and did not use regular contraceptives (21%). 97.9% came within 72 hours and 98% had one unprotected intercourse (Hong Kong Medical Journal 2012;18:299-303). Almost 90% of them used EC only once and 10% used it twice or thrice in one year (International Journal of Gynecology & Obstetrics 2012; 118: 223-6).

Concerning women’s attitude towards advanced provision of ECP, the questionnaire survey conducted among women attending the FPAHK BCC and YHCC in 2003 (Contraception 2005; 71:432-437) showed that less than half of them supported it. Those who supported advanced provision believed that it was more convenient and could prevent unplanned pregnancy. Those who opposed this new delivery mode were concerned about the risks of misuse, encouraging irresponsible sex, and drug side-effects which necessitated doctor’s supervision. Before they filled in the questionnaire, these participants were not given any EC education or information about advanced provision. In contrast, participants in the advanced provision study were more supportive of it. Both groups were educated on EC and advanced provision when they were recruited into the study. 85% of the subjects in the advanced provision group and 77% of subjects in the clinic group supported advanced provision of ECP. This showed that more education on the use of ECP and its advanced provision was needed to enhance women’s awareness, and personal experience with advanced provision might further enhance the acceptance of this new service delivery mode, Dr Lo said.

Dr Lo re-emphasized that contraceptive counseling is important to help women understand why ECP could not replace regular contraceptives, that it is a crucial back-up especially among couples using condoms and other less effective contraceptive methods, and that it should be taken as soon as possible within 72 hours after unprotected sex.